Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAMI) mRNA in bone marrow of down syndrome children during the acute phase of AML(M7)

Genes Chromosomes and Cancer

Volumn 23, Issue 1, 1998, Pages 61-66

  Ives, Jane H ^a   Dagna Bricarelli, Franca ^b   Basso, Giuseppe ^c   Antonarakis, Stylianos E ^d   Jee, Roger ^a   Cotter, Finbarr ^e   Nižetić, Dean ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GALLIERA HOSPITAL   (Italy)

^c 2Nd Pediatric Clinic   (Italy)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CANCER INVASION; CANCER RISK; CHROMOSOME 21; DATA ANALYSIS; DOWN SYNDROME; GENE EXPRESSION; HUMAN; LEUKEMOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELAPSE; REMISSION; RNA ANALYSIS; TRISOMY 21;

ACUTE DISEASE; BONE MARROW; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INFANT; INFANT, NEWBORN; KARYOTYPING; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; PROTEINS; REMISSION INDUCTION; RNA, MESSENGER; TRISOMY;

TRIXIS;

EID: 0031948961     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199809)23:1<61::AID-GCC9>3.0.CO;2-4     Document Type: Article

References (18)

1. Abe K, Kajii T, Niikawa N (1989) Disomie homozygosity in 21-trisomic cells: A mechanism responsible for transient myeloproliferative syndrome. Hum Genet 82:313-316.
2. Chen HM, Antonarakis SE (1995) Localization of a human homolog of the mouse TIAM1 gene to chromosome 21q22.1. Genomics 30:123-127.
3. Chessells JM (1991) Myelodysplasia. In I.M. Hann, B.E.S. Gibson (eds): Clinical Haematology, Vol. 4. London, UK: Bailliere Tindal.
4. Epstein CJ (1993) The Phenotypic Mapping of Down Syndrome and Other Aneuploid Conditions. Proceedings of a National Down Syndrome Society Conference. New York: Wiley-Liss.
5. Fong C-T, Brodeur GM (1987) Down syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet 28:55-76.
6. Habets GGM, Scholtes EHM, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG (1994) Identification of an invasion-inducing gene, TIAM1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77:537-549.
7. Habets GGM, van der Kammen RA, Stam JC, Michiels F, Collard JG (1995) Sequence of the human invasion-inducing TIAM1 gene, its conservation in evolution and its expression in tumor cell lines of different tissue origin. Oncogene 10:1371-1376.
8. Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G (1996) A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: Best outcome in girls, infants and children with Down's syndrome. Br J Haem 94:82-88.
9. Lu G, Altman AJ, Benn PA (1993) Review of the cytogenetic changes in acute megakaryoblastic leukemia: One disease or several? Cancer Genet Cytogenet 67:81-89.
10. Ohta T, Nakano M, Tsujita T, Abe K, Osoegawa K, Yamagata T, Yoshiura K, Jinno Y, Soeda E, Nakamura Y, Niikawa N (1996) Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis. Am J Hum Genet 58:544-550.
11. Robison LL, Neglia JP (1987) Epidemiology of Down syndrome and childhood acute leukemia. In E.E. McCoy, C.J. Epstein (eds): Oncology and Immunology of Down Syndrome, New York: Alan Liss, pp. 19-32.
12. Rowley JD (1981) Down syndrome and acute leukaemia: Increased risk may be due to trisomy 21. Lancet ii: 1020-1022.
13. Sacchi N (1992) Down syndrome and chromosome 21 abnormalities in leukaemia. Balliere's Clin Haematol 5:815-831.
14. Shen JJ, Williams BJ, Zipursky A, Doyle J, Sherman SL, Jacobs PA, Shugar AL, Soukup SW, Hassold TJ (1995) Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am J Hum Genet 56:915-925.
15. Slordahl SH, Gustafsson G, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Lie SO (1992) Down's syndrome (DS) and acute myelogenous leukaemia (AML). A population based study in five Nordic countries. Med Paediatr Oncol 20:373 (abstr.).
16. Slordahl SH, Smeland EB, Holte H, Gronn M, Lie SO, Seip M (1993) Leukaemic blasts with markers of four cell lineages in Downs-syndrome (megakaryoblastic leukaemia). Med Paediatr Oncol 21:254-258.
17. Tobal K, Liu Yin JA (1996) Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21). Blood 88:3704-3709.
18. Zipursky A, Poon A, Doyle J (1992) Leukemia in Down syndrome: A review. Pediatr Hematol Oncol 9:139-149.